Cargando…

Ω76: A designed antimicrobial peptide to combat carbapenem- and tigecycline-resistant Acinetobacter baumannii

Drug resistance is a public health concern that threatens to undermine decades of medical progress. ESKAPE pathogens cause most nosocomial infections, and are frequently resistant to carbapenem antibiotics, usually leaving tigecycline and colistin as the last treatment options. However, increasing t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagarajan, Deepesh, Roy, Natasha, Kulkarni, Omkar, Nanajkar, Neha, Datey, Akshay, Ravichandran, Sathyabaarathi, Thakur, Chandrani, T., Sandeep, Aprameya, Indumathi V., Sarma, Siddhartha P., Chakravortty, Dipshikha, Chandra, Nagasuma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656545/ https://www.ncbi.nlm.nih.gov/pubmed/31355341 http://dx.doi.org/10.1126/sciadv.aax1946

Ejemplares similares

VB(10), a new blood biomarker for differential diagnosis and recovery monitoring of acute viral and bacterial infections
por: Ravichandran, Sathyabaarathi, et al.
Publicado: (2021)

A Strategic Target Rescues Trimethoprim Sensitivity in Escherichia coli
por: Bhosle, Amrisha, et al.
Publicado: (2020)

A new blood-based RNA signature (R(9)), for monitoring effectiveness of tuberculosis treatment in a South Indian longitudinal cohort
por: Thakur, Chandrani, et al.
Publicado: (2022)

Insights into the mechanism of a novel shockwave-assisted needle-free drug delivery device driven by in situ-generated oxyhydrogen mixture which provides efficient protection against mycobacterial infections
por: Subburaj, Janardhanraj, et al.
Publicado: (2017)

Mechanism of transformation in Mycobacteria using a novel shockwave assisted technique driven by in-situ generated oxyhydrogen
por: Datey, Akshay, et al.
Publicado: (2017)

Chronic lung infection by Pseudomonas aeruginosa biofilm is cured by L-Methionine in combination with antibiotic therapy
por: Gnanadhas, Divya Prakash, et al.
Publicado: (2015)

Novel Cell-Based Assay to Investigate Monoacylglycerol Acyltransferase 2 Inhibitory Activity Using HIEC-6 Cell Line
por: Singh, Yeshvanthi, et al.
Publicado: (2021)

Shockwave Therapy Efficiently Cures Multispecies Chronic Periodontitis in a Humanized Rat Model
por: Datey, Akshay, et al.
Publicado: (2019)

A Simple Radioassay to Detect Nanoscale Membrane Disruption
por: Nanajkar, Neha, et al.
Publicado: (2023)

Successful treatment of biofilm infections using shock waves combined with antibiotic therapy
por: Gnanadhas, Divya Prakash, et al.
Publicado: (2015)

Corrigendum: Successful treatment of biofilm infections using shock waves combined with antibiotic therapy
por: Gnanadhas, Divya Prakash, et al.
Publicado: (2018)

The Transcriptomic Signature of Tigecycline in Acinetobacter baumannii
por: Li, Liping, et al.
Publicado: (2020)

Resistance mechanisms of tigecycline in Acinetobacter baumannii
por: Sun, Chunli, et al.
Publicado: (2023)

Tigecycline Versus Colistin in the Treatment of Carbapenem-resistant Acinetobacter baumannii Complex Osteomyelitis
por: Oliveira, Priscila R., et al.
Publicado: (2020)

A Safe Vaccine (DV-STM-07) against Salmonella Infection Prevents Abortion and Confers Protective Immunity to the Pregnant and New Born Mice
por: Negi, Vidya Devi, et al.
Publicado: (2010)

Heterogeneity in pneumolysin expression governs the fate of Streptococcus pneumoniae during blood-brain barrier trafficking
por: Surve, Manalee Vishnu, et al.
Publicado: (2018)

In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumannii
por: Abdul-Mutakabbir, Jacinda C., et al.
Publicado: (2021)

Virulence profile: Dipshikha Chakravortty
por: Chakravortty, Dipshikha
Publicado: (2014)

Report from the “Global Health Meets Infection Biology” LSS2012 Program: Infectious diseases and their management, a light at the end of tunnel? August 2012
por: Chakravortty, Dipshikha
Publicado: (2013)

Polymyxin B/Tigecycline Combination vs. Polymyxin B or Tigecycline Alone for the Treatment of Hospital-Acquired Pneumonia Caused by Carbapenem-Resistant Enterobacteriaceae or Carbapenem-Resistant Acinetobacter baumannii
por: Chang, Kang, et al.
Publicado: (2022)

Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant Acinetobacter baumannii
por: Niu, Tianshui, et al.
Publicado: (2019)

Role of efflux pumps in reduced susceptibility to tigecycline in Acinetobacter baumannii
por: Ardehali, S.H., et al.
Publicado: (2019)

Tigecycline Heteroresistance and Resistance Mechanism in Clinical Isolates of Acinetobacter baumannii
por: Jo, Jeongwoo, et al.
Publicado: (2021)

PLIC: protein–ligand interaction clusters
por: Anand, Praveen, et al.
Publicado: (2014)

ABS–Scan: In silico alanine scanning mutagenesis for binding site residues in protein–ligand complex
por: Anand, Praveen, et al.
Publicado: (2014)

In vitro activity of tigecycline and comparators against carbapenem-susceptible and resistant Acinetobacter baumannii clinical isolates in Italy
por: Mezzatesta, Maria Lina, et al.
Publicado: (2008)

Clinical Outcomes of Tigecycline in the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection
por: Shin, Jung Ar, et al.
Publicado: (2012)

Effects of In vivo Emergent Tigecycline Resistance on the Pathogenic Potential of Acinetobacter baumannii
por: Hornsey, Michael, et al.
Publicado: (2018)

COMPARISON OF TWO DIFFERENT METHODS FOR TIGECYCLINE SUSCEPTIBILITY TESTING IN ACINETOBACTER BAUMANNII
por: Bedenić, Branka, et al.
Publicado: (2018)

Characterization of Increased Extracellular Vesicle-Mediated Tigecycline Resistance in Acinetobacter baumannii
por: Cho, Hyejin, et al.
Publicado: (2023)

The Mechanism of Tigecycline Resistance in Acinetobacter baumannii Revealed by Proteomic and Genomic Analysis
por: Liu, Cunwei, et al.
Publicado: (2023)

Epithelial Cell Damage Activates Bactericidal/Permeability Increasing-Protein (BPI) Expression in Intestinal Epithelium
por: Balakrishnan, Arjun, et al.
Publicado: (2017)

In-Vitro Activity of Polymyxin B, Rifampicin, Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii in Singapore
por: Lim, Tze-Peng, et al.
Publicado: (2011)

In vitro activity of tigecycline against clinical isolates of carbapenem resistant Acinetobacter baumannii complex in Pretoria, South Africa
por: Ahmed, Nahid H, et al.
Publicado: (2012)

Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant Acinetobacter baumannii Pneumonia
por: Park, Jae-Min, et al.
Publicado: (2021)

lac Repressor Is an Antivirulence Factor of Salmonella enterica: Its Role in the Evolution of Virulence in Salmonella
por: Eswarappa, Sandeepa M., et al.
Publicado: (2009)

Halobacterial nano vesicles displaying murine bactericidal permeability-increasing protein rescue mice from lethal endotoxic shock
por: Balakrishnan, Arjun, et al.
Publicado: (2016)

Delirium induced by tigecycline treatment for Acinetobacter baumannii infection: A case report
por: Zheng, Xiaoying, et al.
Publicado: (2019)

Comparative Genomic Analysis of 19 Clinical Isolates of Tigecycline-Resistant Acinetobacter baumannii
por: Liu, Lin, et al.
Publicado: (2020)

Genomic and Phenotypic Evolution of Tigecycline-Resistant Acinetobacter baumannii in Critically Ill Patients
por: Zhang, Jiangang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gssfmud2tvtfd637l5almghj5g